Table 2.
Characteristics of the subgroup analysis for advanced ovarian cancer stages (FIGO III and IV) study and control group
| Advanced ovarian cancer group | Study Group (n=87) | Control Group (n=96) |
|---|---|---|
| Age (in years) | mean: 62.83 | mean: 64.17 |
| Tumor stage | ||
| FIGO III | 63.2% (n=55 ) | 62.5% (n=60 ) |
| FIGO IV | 36.8% (n=32 ) | 37.5% (n=36 ) |
| Histology | ||
| High-grade serous ovarian carcinoma | 93.8% (n=60 ) | 90.0% (n=54 ) |
| Mucinous ovarian carcinoma | 1.6% (n=1 ) | 0.0% (n=0 ) |
| Endometrioid ovarian carcinoma | 1.6% (n=1 ) | 3.3% (n=2 ) |
| Clear cell ovarian carcinoma | 3.1% (n=2 ) | 6.7% (n=4 ) |
| NACT performed | 65.5% (n=57 ) | 60.4% (n=58 ) |
| Colonoscopy Findings | ||
| Abnormality | 42.5% (n=37 ) | |
| Colorectal resection/shaving | ||
| Resection | 36.8% (n=32) | 27.1% (n=26) |
| Shaving | 4.6% (n=4) | 2.1% (n=2 ) |
| Inoperability | 25.3% (n=22) | 27.1% (n=26) |
| No infestation (appendectomy for muc. carcinoma if necessary) | 33.3% (n=29) | 42.7% (n=41) |
| Postoperative tumor residue | ||
| Macroscopic complete resection | 63.2% (n=55) | 63.5% (n=61) |
| No macroscopic complete resection | 36.8% (n=32) | 36.5% (n=35) |